What certifications does the product have?

The product is certified under ISO and GMP standards.

What are the main benefits of using this probiotic?

It improves intestinal health, boosts immunity, enhances feed utilization, and reduces the need for antibiotics.

Hot Sale Veterinary Feed Additives Mixed Probiotics (Animal Use) ISO GMP

Name: Hot Sale Veterinary Feed Additives Mixed Probiotics (Animal Use) ISO GMP
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1975327192

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$790.00-900.00

10 Tons

Sample price:US$1.00/kg.Request sample

Product profile

Customization

Available

Certification

ISO, ISO

Shape

Powder

Model NO.

powder

Function

Bacteriostasis Growth Promoter

Type

Functional Additives

Transport Package

25kg/Carton; 25kg/Dump

Specification

1kg/bag; 25kg/bag

Trademark

MOOSUN

Origin

China

HS Code

2309901000

Production Capacity

500t/Months

Key features

Growth & Health Promotion: Improves digestion, feed utilization, immunity, and egg production quality in livestock and poultry.

Antibiotic Reduction: Rich in curcumin for anti-inflammatory and antioxidant effects, reducing reliance on antibiotics.

ISO GMP Certified: Manufactured under strict ISO and GMP standards ensuring high quality and safety.

Safe & Pure Formula: Free from Salmonella, with strict limits on Lead, Arsenic, and Aflatoxin B1.

Custom OEM/ODM Service: Supports OEM and ODM services with 20 R&D engineers for tailored solutions.

Manufacturer Direct: Direct supply from Muxiang Group with 20 years of experience and large production capacity.

Flexible Packaging: Available in 1kg/bag and 25kg/bag options for convenient storage and usage.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤10.73h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.